OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 4.40 -0.15 (-3.30%)
As of 11:57 AM Eastern

OPTI vs. MXC, RGT, CEL, IDP, and HALO

Should you buy OptiBiotix Health stock or one of its competitors? OptiBiotix Health's main competitors and comparable companies include Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), InnovaDerma (IDP), and HaloSource (HALO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does OptiBiotix Health compare to Argent BioPharma?

OptiBiotix Health (LON:OPTI) and Argent BioPharma (LON:MXC) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

OptiBiotix Health has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market. Comparatively, Argent BioPharma has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

Argent BioPharma has a net margin of 0.00% compared to OptiBiotix Health's net margin of -332.69%. Argent BioPharma's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-332.69% -77.85% -13.93%
Argent BioPharma N/A N/A -58.96%

OptiBiotix Health has higher earnings, but lower revenue than Argent BioPharma. OptiBiotix Health is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.29M3.65-£3.09M-£4.21N/A
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A

In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled Argent BioPharma'saverage media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
Argent BioPharma Neutral

0.4% of OptiBiotix Health shares are held by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by company insiders. Comparatively, 8.2% of Argent BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

OptiBiotix Health and Argent BioPharma tied by winning 5 of the 10 factors compared between the two stocks.

How does OptiBiotix Health compare to Argent BioPharma?

Argent BioPharma (LON:RGT) and OptiBiotix Health (LON:OPTI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

OptiBiotix Health has higher revenue and earnings than Argent BioPharma. OptiBiotix Health is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argent BioPharmaN/AN/A-£17.53M-£0.24N/A
OptiBiotix Health£1.29M3.65-£3.09M-£4.21N/A

Argent BioPharma has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market. Comparatively, OptiBiotix Health has a beta of 1.82, suggesting that its share price is 82% more volatile than the broader market.

1.1% of Argent BioPharma shares are held by institutional investors. Comparatively, 0.4% of OptiBiotix Health shares are held by institutional investors. 17.8% of Argent BioPharma shares are held by insiders. Comparatively, 26.8% of OptiBiotix Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Argent BioPharma's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
Argent BioPharma Neutral
OptiBiotix Health Neutral

OptiBiotix Health has a net margin of -332.69% compared to Argent BioPharma's net margin of -1,967.38%. Argent BioPharma's return on equity of 279.26% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Argent BioPharma-1,967.38% 279.26% -108.57%
OptiBiotix Health -332.69%-77.85%-13.93%

Summary

OptiBiotix Health beats Argent BioPharma on 6 of the 10 factors compared between the two stocks.

How does OptiBiotix Health compare to Celadon Pharmaceuticals?

OptiBiotix Health (LON:OPTI) and Celadon Pharmaceuticals (LON:CEL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

0.4% of OptiBiotix Health shares are held by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by company insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OptiBiotix Health has a net margin of -332.69% compared to Celadon Pharmaceuticals' net margin of -9,520.00%. OptiBiotix Health's return on equity of -77.85% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-332.69% -77.85% -13.93%
Celadon Pharmaceuticals -9,520.00%-131.82%-34.40%

OptiBiotix Health has higher revenue and earnings than Celadon Pharmaceuticals. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.29M3.65-£3.09M-£4.21N/A
Celadon Pharmaceuticals£123.38K66.61-£4.97M-£7.98N/A

In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
Celadon Pharmaceuticals Neutral

OptiBiotix Health has a beta of 1.82, meaning that its share price is 82% more volatile than the broader market. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, meaning that its share price is 126% less volatile than the broader market.

Summary

OptiBiotix Health beats Celadon Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does OptiBiotix Health compare to InnovaDerma?

InnovaDerma (LON:IDP) and OptiBiotix Health (LON:OPTI) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

0.4% of OptiBiotix Health shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

InnovaDerma has a net margin of 0.00% compared to OptiBiotix Health's net margin of -332.69%. InnovaDerma's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
InnovaDermaN/A N/A N/A
OptiBiotix Health -332.69%-77.85%-13.93%

In the previous week, InnovaDerma's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
InnovaDerma Neutral
OptiBiotix Health Neutral

InnovaDerma has higher revenue and earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than InnovaDerma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InnovaDerma£9.82M0.00N/A-£7.50N/A
OptiBiotix Health£1.29M3.65-£3.09M-£4.21N/A

Summary

InnovaDerma and OptiBiotix Health tied by winning 4 of the 8 factors compared between the two stocks.

How does OptiBiotix Health compare to HaloSource?

HaloSource (LON:HALO) and OptiBiotix Health (LON:OPTI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

HaloSource has higher earnings, but lower revenue than OptiBiotix Health. HaloSource is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HaloSourceN/AN/AN/A-£3.72N/A
OptiBiotix Health£1.29M3.65-£3.09M-£4.21N/A

0.4% of OptiBiotix Health shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, HaloSource's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
HaloSource Neutral
OptiBiotix Health Neutral

HaloSource has a net margin of 0.00% compared to OptiBiotix Health's net margin of -332.69%. HaloSource's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
HaloSourceN/A N/A N/A
OptiBiotix Health -332.69%-77.85%-13.93%

Summary

HaloSource and OptiBiotix Health tied by winning 4 of the 8 factors compared between the two stocks.

Get OptiBiotix Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

MetricOptiBiotix HealthPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£4.55M£13.76B£7.83B£2.84B
Dividend YieldN/A2.58%2.47%5.11%
P/E Ratio-1.0529.0734.3423.37
Price / Sales3.537.758.005.05
Price / Cash8.6815.7421.0220.23
Price / Book0.565.194.762.51
Net Income-£3.09M£2.88B£3.52B£5.88B
7 Day Performance-20.00%-3.87%-5.34%-0.01%
1 Month Performance-24.14%-3.96%-3.61%-2.15%
1 Year Performance-44.30%-7.13%0.01%7.21%

OptiBiotix Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 4.40
-3.3%
N/A-42.4%£4.55M£1.29MN/A1
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/AN/AN/A
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38KN/A2,780
IDP
InnovaDerma
N/AN/AN/AN/A£8.14M£9.82MN/A8,720

Related Companies and Tools


This page (LON:OPTI) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners